Purdue Pharma LP Clinical Trials
Sponsors / Purdue Pharma LP
According to ClinicalTrials.gov, Purdue Pharma LP has served as lead sponsor on 59 registered trials. 0 trials are actively recruiting participants, 0 remain active without open enrollment, and 47 have concluded. 12 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include safety concerns, business or strategic decisions. The cumulative planned enrollment figure across all listed trials is 13,659 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
59
Total Trials
0
Recruiting
0
Other Active
47
Completed
12
Terminated / Withdrawn
13,659
Total Enrollment
Termination reasons: Safety50% · Other42% · Business8%
Recent Terminations
- Attention Deficit/Hyperactivity Disorder"due to administrative reasons not related to efficacy or safety."
- Attention-Deficit/Hyperactivity Disorder"(due to administrative reasons not related to efficacy or safety.)"
- Osteoarthritis Pain of the Knee"Company decision"
- Postsurgical Pain Due to Third Molar Extraction"Terminated early due to administrative reasons not related to safety."
- Back Pain Lower Back Chronic"Terminated early due to administrative reasons."
- Postoperative Pain"due to administrative reasons not related to efficacy or safety."
- Osteoarthritis"This study was terminated early for administrative reasons."
- Chronic Non-Malignant Pain
- Osteoarthritis"This study was terminated early due to administrative reasons."
- Osteoarthritis"Administrative reasons."